- JNJ +0.63%
Beyond Market Price: Uncovering Johnson & Johnson's Intrinsic Value
Yahoo Finance · 5 days ago
Open | 159.75 |
High | 161.58 |
Low | 159.48 |
Mkt Cap | 386.61B |
P/E (TTM) | 24.30 |
Div & Yield | 4.96 & 3.11% |
Prev. Close | 159.64 |
52 Wk. Low | 143.13 |
52 Wk. High | 175.97 |
Related stocks
U.S multinational medical devices, pharmaceutical and consumer packaged goods manufacturer
Johnson & Johnson is an American multinational pharmaceutical, biotechnology, and medical technologies corporation headquartered in New Brunswick, New Jersey, and publicly traded on the New York Stock Exchange. Wikipedia
(USD) | Q2 2024 | Y/Y |
---|---|---|
Revenue | 22.45B | - |
Net Income | 4.69B | - |
Diluted EPS | 2.60 | - |
Quarter | EPS Estimate | EPS Actual |
---|---|---|
Q3 2024 | $2.01 | - |
Q2 2024 | $2.49 | $2.60 |
Q1 2024 | $2.64 | $2.71 |
S&P 500^GSPC | 5,459.10+59.88 (+1.11%) |
Dow 30^DJI | 40,589.34+654.27 (+1.64%) |
Nasdaq^IXIC | 17,357.88+176.16 (+1.03%) |
3M CompanyMMM | 127.16+22.99% |
40,589.34+1.64% | |
Dutch Bros Inc.BROS | 38.02+2.31% |